Tweet
Fox News
<img alt="" height="1" width="1" />
Sanofi MS drug shines, biotech strategy advances
FierceBiotech
Sanofi is seeing its increased focus on biotech drugs go according to plan, with positive results today from a late-stage trial of a multiple sclerosis treatment, Lemtrada, which the French drugmaker picked up through its $20 billion-plus buyout of ...
Sanofi-Aventis' MS Drug Candidate Meets First Primary Goal Of Trial - UpdateRTT News
Sanofi's Lemtrada Helps Multiple Sclerosis Patients in StudyBloomberg
Sanofi-Genzyme MS Drug: Mixed ResultsTheStreet.com
Reuters -MarketWatch -Genetic Engineering News
all 39 news articles »
More...